The Board of Renishaw plc announces the appointment of John Jeans CBE CEng as a non-executive director.
Aged 63, John brings to the table more than 35 years of strong industrial experience, having held senior leadership positions in several global companies including Smith & Nephew, Bristol Myers Squibb, Johnson & Johnson and Amersham plc (now GE Healthcare). His experience ranges from medical devices and pharmaceuticals to in-vivo and in-vitro diagnostics encompassing research, product development, manufacturing and commercialisation.
Currently Chairman of the Council of Cardiff University and Imanova (an imaging research partnership between three London Universities and the Medical Research Council), John also chairs the Board of MRC Technology and is a non-executive director of the Alliance Medical Group. He is also a Board member of the University and College Employers Association.
As an advisor to several public sector organisations, John currently chairs the Technology Strategy Board's stratified medicine advisory board, in addition to being a Steering Board member of the HealthTech and Medicines Knowledge Transfer Network and an advisor to the University of Manchester's venture fund.
John will also become a member of Renishaw plc's Audit Committee, Remuneration Committee and Nomination Committee.
Welcoming John to the Board, Sir David McMurtry CBE RDI FRS FREng CEng FIMechE, Chairman and Chief Executive said that John’s extensive experience in the healthcare industry and in engineering technologies makes him a valuable addition to the Company's resources at the board level.
Renishaw Oceania represents the Renishaw Group in Australia.